Table 2 A comparison of blood biochemistry data between the EPO-resistant and non-EPO-resistant HD patients
Item | Non-EPO resistance | EPO resistance | P value |
|---|---|---|---|
N | 98 | 36 | |
Ferritin (ng/ml) | 445.4 ± 330.8 | 472.9 ± 310.0 | 0.668 |
SI (μg/dl) | 62.6 ± 22.3 | 57.8 ± 24.8 | 0.293 |
TSAT (%) | 25.6 ± 11.2 | 24.5 ± 10.0 | 0.618 |
TIBC (μg/dl) | 257.7 ± 58.0 | 241.4 ± 64.0 | 0.167 |
i-PTH (pg/ml) | 417.7 ± 460.0 | 514.0 ± 609.0 | 0.331 |
Hematocrit (%) | 33.5 ± 2.4 | 31.3 ± 2.7 | <0.001 |
Albumin (g/dl) | 4.0 ± 0.3 | 3.9 ± 0.4 | 0.173 |
Phosphate (mg/dl) | 5.3 ± 1.5 | 5.6 ± 1.5 | 0.233 |
Calcium (mg/dl) | 9.4 ± 0.8 | 9.2 ± 0.9 | 0.224 |
Gas6 (ng/ml) | 13.7 ± 3.2 | 15.4 ± 3.3 | 0.006 |
IL-6 (pg/ml) | 2.1 ± 1.5 | 3.1 ± 3.1 | 0.009 |
hs-CRP (mg/l) | 4.5 ± 5.5 | 12.7 ± 25.2 | 0.002 |
Kt/V | 1.79 ± 0.29 | 1.73 ± 0.32 | 0.272 |
RBC fragility test (% of NaCl) | 0.413 ± 0.05 | 0.417 ± 0.04 | 0.700 |